Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms by Histologic Type × Tumor-Agnostic × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Lymphoid 4 Plasma cell 3 Tumor-Agnostic 1 Thoracic 1 Other hematologic neoplasm 1 Head & Neck 1 Gynecologic 1 CNS 1

Conditions

Neoplasms 387 Neoplasm Metastasis 77 Carcinoma, Squamous Cell 20 Adenocarcinoma 17 Carcinoma 15 Neoplasms, Unknown Primary 6 Neoplasm, Residual 6 Neoplasms, Second Primary 5 Neoplasms by Histologic Type 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06175780 2023-12-26

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Phase 1 Unknown

Neoplasms, Neoplasms by Histologic Type

Data powered by HemOnc (CC BY 4.0) Colophon ⚡